Anti-human Igβ antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10316086
APP PUB NO 20170226207A1
SERIAL NO

15501626

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

[Problem] Provided is an anti-human Igβ antibody which crosslinks BCR and FcγRIIb and has an immunosuppressive function more enhanced than that of an antibody in the prior art.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASTELLAS PHARMA INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Honda, Takashi Tokyo, JP 219 2313
Kubo, Satoshi Tokyo, JP 34 172
Morinaka, Akifumi Tokyo, JP 9 31
Seki, Mutsumi Tokyo, JP 2 8
Soga, Shinji Tokyo, JP 6 12
Yamajuku, Daisuke Tokyo, JP 6 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 11, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 11, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00